VP Clinical Pharmacology Modeling & Simulation Oncology
GlaxoSmithKline
Sandra Visser is VP, Head of Oncology Clinical Pharmacology Modelling and Simulation at GSK with a current secondment to the gobal development governance board secretariat. She is passionate about application of quantitative and translational pharmacology, clinical pharmacology, and pharmacometrics in drug development with the aim to improve R&D decision making. In addition, she is a strong advocate for DE&I related activities within her organization. Sandra received her PhD in quantitative pharmacology from Leiden University in The Netherlands, and since then worked and lived in both Sweden and United States. She has been a member of ASCPT since 2014 and has served the society in leadership roles for the Scientific Programming Committee, QP network, and Awards committee and also has chaired special educational events
How Could Debunking Biases in R&D Decisions Lead to More Equitable Healthcare?
Thursday, March 23, 2023
9:30 AM – 10:30 AM EDT